Cargando…

Drug–drug interactions between treatment specific pharmacotherapy and concomitant medication in patients with COVID-19 in the first wave in Spain

Primary aim was to assess prevalence and severity of potential and real drug–drug interactions (DDIs) among therapies for COVID-19 and concomitant medications in hospitalized patients with confirmed SARS-CoV-2 infection. The secondary aim was to analyze factors associated with rDDIs. An observationa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cantudo-Cuenca, M. D., Gutiérrez-Pizarraya, Antonio, Pinilla-Fernández, Ana, Contreras-Macías, Enrique, Fernández‑Fuertes, M., Lao‑Domínguez, F. A, Rincón, Pilar, Pineda, Juan Antonio, Macías, Juan, Morillo-Verdugo, Ramón
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203634/ https://www.ncbi.nlm.nih.gov/pubmed/34127740 http://dx.doi.org/10.1038/s41598-021-91953-2

Ejemplares similares

High rate of major drug–drug interactions of lopinavir–ritonavir for COVID-19 treatment
por: Macías, Juan, et al.
Publicado: (2020)

High level of medication regimen complexity index correlate with worse quality of life in people living with HIV
por: Contreras-Macías, Enrique, et al.
Publicado: (2021)

Prevalence of prescription of the Top-10 drug classes to avoid in elderly people living with HIV in a real practice cohort
por: Macías, Enrique Contreras, et al.
Publicado: (2020)

Incidence of and factors associated with SARS‐CoV‐2 infection among people living with HIV in Southern Spain after one year of pandemic
por: Fernandez‐Fuertes, Marta, et al.
Publicado: (2021)

Concurrent Use of Comedications Reduces Adherence to Antiretroviral Therapy Among HIV-Infected Patients
por: Cantudo-Cuenca, Maria Rosa, et al.
Publicado: (2014)

Safety and efficacy of pharmacotherapy containing INSTIs and chemotherapy drugs in people living with HIV and concomitant colorectal cancer
por: Yang, Jing, et al.
Publicado: (2022)

Lower probability of persistence of total anti-SARS-CoV-2 antibodies after COVID-19 among people living with HIV
por: Macías, Juan, et al.
Publicado: (2022)

Drug pollution and pharmacotherapy in psychiatry: A “platypus” in the room
por: Lertxundi, Unax, et al.
Publicado: (2020)

Kidney Drug Transporters in Pharmacotherapy
por: Łapczuk-Romańska, Joanna, et al.
Publicado: (2023)

No evidence of firstly acquired acute hepatitis C virus infection outbreak among HIV-infected patients from Southern Spain: a multicentric retrospective study from 2000-2014
por: Neukam, Karin, et al.
Publicado: (2016)

Adherence to disease-modifying treatments in patients with multiple sclerosis in Spain
por: Morillo Verdugo, Ramón, et al.
Publicado: (2019)

Drug Efficacy Monitoring in Pharmacotherapy of Multiple Sclerosis With Biological Agents
por: Caldano, Marzia, et al.
Publicado: (2017)

Influence of CMO pharmaceutical care model-based intervention on readmission rate in high risk HIV patients: the INFARDAR study
por: Ramos, Maria Isabel Guzman, et al.
Publicado: (2021)

Potentially inappropriate medications according to Marc, STOPP and PRISCUS criteria in a cohort of elderly HIV+ patients. The COMMPI project
por: García-Lloret, Patricia, et al.
Publicado: (2022)

Similar prevalence of hepatic steatosis among patients with chronic hepatitis C with and without HIV coinfection
por: Fernandez-Fuertes, M., et al.
Publicado: (2020)

Similar incidence of coronavirus disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy
por: Macías, Juan, et al.
Publicado: (2021)

Mesenchymal stromal cells for the prophylaxis and treatment of graft-versus-host disease—a meta-analysis
por: Morata-Tarifa, Cynthia, et al.
Publicado: (2020)

Characterization of Streptococcus pyogenes from Animal Clinical Specimens, Spain
por: Vela, Ana Isabel, et al.
Publicado: (2017)

Beliefs and attitudes about deprescription in older HIV-infected patients: ICARD Project
por: Giménez, Reyes Serrano, et al.
Publicado: (2020)

Potential interactions between pangenotypic direct-acting antivirals and concomitant cardiovascular therapies in patients with chronic hepatitis C virus infection
por: Sicras-Mainar, Antoni, et al.
Publicado: (2020)

Some Candidate Drugs for Pharmacotherapy of Alzheimer’s Disease
por: Miziak, Barbara, et al.
Publicado: (2021)

Pharmacotherapy, drug-drug interactions and potentially inappropriate medication in depressive disorders
por: Wolff, Jan, et al.
Publicado: (2021)

Severe immunosuppression is related to poorer immunogenicity to SARS-CoV-2 vaccines among people living with HIV
por: Corma-Gómez, Anaïs, et al.
Publicado: (2022)

Self-Medication of Drugs in Nursing Students from Castile and Leon (Spain)
por: Galán Andrés, Maria Isabel, et al.
Publicado: (2021)

Hepatitis E 3ra Genotype Infection in People Living With HIV in Spain
por: Rivero-Juarez, Antonio, et al.
Publicado: (2020)

Severe acute hepatitis in a person with HIV and simultaneous infection with hepatitis C virus and SARS-CoV-2
por: Santos, Marta, et al.
Publicado: (2023)

Severe acute hepatitis in a person with HIV and simultaneous infection with hepatitis C virus and SARS-CoV-2
por: Santos, Marta, et al.
Publicado: (2023)

Controlled attenuation parameter-insulin resistance (CIR) score to predict non-alcoholic steatohepatitis
por: Macias, Juan, et al.
Publicado: (2022)

Evaluation of Patient Experience with a Model of Coordinated Telematic Pharmaceutical Care Between Hospital and Rural Pharmacies in Spain [Response To Letter]
por: Morillo-Verdugo, Ramón, et al.
Publicado: (2023)

Evaluation of Patient Experience With A Model of Coordinated Telematic Pharmaceutical Care Between Hospital and Rural Pharmacies in Spain: A Proof of Concept
por: Morillo-Verdugo, Ramón, et al.
Publicado: (2023)

Epidemiology of non-steroidal anti-inflammatory drugs consumption in Spain. The MCC-Spain study
por: Gómez-Acebo, Inés, et al.
Publicado: (2018)

Potential Drug Interactions of Repurposed COVID-19 Drugs with Lung Cancer Pharmacotherapies
por: Baburaj, Gayathri, et al.
Publicado: (2021)

Hidden Paradoxes in Generic Drug Substitution Affecting Pharmacotherapy
por: Sapone, A., et al.
Publicado: (2009)

Experimental and Investigational Pharmacotherapy for Psoriatic Arthritis: Drugs of the Future
por: Navarini, Luca, et al.
Publicado: (2020)

Pharmacotherapy of Adolescent Alcohol and Other Drug Use Disorders
por: Solhkhah, Ramon, et al.
Publicado: (1998)

Pharmacotherapy of the Lipid-Lowering Drugs: Update on Efficacy and Risk
por: Pierno, Sabata, et al.
Publicado: (2023)

Novel Drug Targets and Emerging Pharmacotherapies in Neuropathic Pain
por: Bernatoniene, Jurga, et al.
Publicado: (2023)

Mortality trends for accidental falls in older people in Spain, 2000-2015
por: Padrón-Monedero, Alicia, et al.
Publicado: (2017)

Hepatic Steatosis and Weight Gain During the Coronavirus Disease 2019 Pandemic Among People With Human Immunodeficiency Virus: Impact of Therapy With Tenofovir Alafenamide
por: Santos, Marta, et al.
Publicado: (2023)

Can pharmacogenetics explain efficacy and safety of cisplatin pharmacotherapy?
por: Roco, Ángela, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_cruc84vjne0omvovo7s4drp466